The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 12, 2014

Filed:

Oct. 04, 2011
Applicants:

Soman Abraham, Chapel Hill, NC (US);

Kam Leong, Durham, NC (US);

Herman Staats, Cedar Grove, NC (US);

Ashley St. John, Durham, NC (US);

Inventors:

Soman Abraham, Chapel Hill, NC (US);

Kam Leong, Durham, NC (US);

Herman Staats, Cedar Grove, NC (US);

Ashley St. John, Durham, NC (US);

Assignee:

Duke University, Durham, NC (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/20 (2006.01); A61K 38/21 (2006.01); B82Y 5/00 (2011.01); A61K 39/145 (2006.01); A61K 38/19 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
B82Y 5/00 (2013.01); A61K 38/2006 (2013.01); A61K 38/208 (2013.01); A61K 38/2066 (2013.01); A61K 2039/55527 (2013.01); A61K 38/21 (2013.01); A61K 2039/55555 (2013.01); A61K 39/0008 (2013.01); A61K 39/145 (2013.01); A61K 38/191 (2013.01); A61K 38/2013 (2013.01); A61K 38/20 (2013.01); Y10S 977/906 (2013.01); Y10S 977/773 (2013.01);
Abstract

Provided are nanoparticles comprising heparin, chitosan, and at least one immunomodulatory agent, e.g. a cytokine. The cytokine can be selected from the group consisting of TNF, IL-12, IL-2, IL-23, IL-1α, IL-10, IL-18, and combinations thereof. Further provided are methods of making a nanoparticle comprising mixing a first composition comprising heparin with a second composition comprising chitosan in the presence of at least one cytokine to form a third composition. Further provided are methods of modulating an immune response comprising co-administering to a subject an antigen or vaccine with nanoparticles comprising heparin, chitosan, and at least one cytokine.


Find Patent Forward Citations

Loading…